A detailed history of Janus Henderson Group PLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Janus Henderson Group PLC holds 15,828 shares of EXAS stock, worth $668,733. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,828
Previous 15,826 0.01%
Holding current value
$668,733
Previous $1.17 Million 6.58%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$56.27 - $73.77 $112 - $147
2 Added 0.01%
15,828 $1.09 Million
Q4 2023

Feb 14, 2024

SELL
$59.06 - $75.72 $8,209 - $10,525
-139 Reduced 0.87%
15,826 $1.17 Million
Q3 2023

Nov 14, 2023

SELL
$65.94 - $99.04 $39,102 - $58,730
-593 Reduced 3.58%
15,965 $1.09 Million
Q2 2023

Aug 14, 2023

SELL
$62.68 - $95.05 $102,669 - $155,691
-1,638 Reduced 9.0%
16,558 $1.55 Million
Q1 2023

May 15, 2023

SELL
$47.19 - $70.77 $62,149 - $93,204
-1,317 Reduced 6.75%
18,196 $1.23 Million
Q4 2022

Feb 14, 2023

BUY
$30.35 - $53.15 $12,018 - $21,047
396 Added 2.07%
19,513 $966,000
Q3 2022

Nov 14, 2022

SELL
$31.97 - $49.37 $125,226 - $193,382
-3,917 Reduced 17.01%
19,117 $621,000
Q2 2022

Aug 15, 2022

SELL
$35.61 - $76.23 $412,897 - $883,886
-11,595 Reduced 33.48%
23,034 $908,000
Q1 2022

May 16, 2022

BUY
$57.56 - $82.54 $1.99 Million - $2.86 Million
34,629 New
34,629 $2.42 Million
Q4 2021

Feb 14, 2022

SELL
$72.5 - $100.68 $4.31 Million - $5.99 Million
-59,466 Closed
0 $0
Q3 2021

Nov 16, 2021

SELL
$90.24 - $124.05 $161,890 - $222,545
-1,794 Reduced 2.93%
59,466 $5.68 Million
Q2 2021

Aug 16, 2021

BUY
$93.66 - $139.27 $99,092 - $147,347
1,058 Added 1.76%
61,260 $7.61 Million
Q1 2021

May 17, 2021

BUY
$116.57 - $155.01 $3.14 Million - $4.18 Million
26,959 Added 81.1%
60,202 $7.93 Million
Q4 2020

Feb 16, 2021

SELL
$99.61 - $142.12 $2.85 Million - $4.07 Million
-28,633 Reduced 46.27%
33,243 $4.41 Million
Q3 2020

Nov 16, 2020

SELL
$72.92 - $102.01 $29.1 Million - $40.7 Million
-399,386 Reduced 86.59%
61,876 $6.31 Million
Q2 2020

Aug 14, 2020

SELL
$55.75 - $92.75 $4.23 Million - $7.04 Million
-75,875 Reduced 14.13%
461,262 $40.1 Million
Q1 2020

May 14, 2020

BUY
$37.9 - $104.44 $598,668 - $1.65 Million
15,796 Added 3.03%
537,137 $31.2 Million
Q4 2019

Feb 18, 2020

BUY
$77.66 - $99.74 $13.2 Million - $17 Million
170,576 Added 48.63%
521,341 $48.2 Million
Q3 2019

Nov 14, 2019

BUY
$90.37 - $122.49 $29.2 Million - $39.6 Million
323,477 Added 1185.42%
350,765 $31.7 Million
Q2 2019

Jul 31, 2019

BUY
$89.51 - $118.04 $1.98 Million - $2.61 Million
22,101 Added 426.08%
27,288 $3.22 Million
Q1 2019

Apr 30, 2019

BUY
$61.98 - $96.5 $321,490 - $500,545
5,187 New
5,187 $449,000
Q3 2018

Nov 09, 2018

SELL
$48.29 - $80.6 $241,450 - $403,000
-5,000 Closed
0 $0
Q2 2018

Aug 10, 2018

BUY
$37.84 - $69.96 $189,200 - $349,799
5,000 New
5,000 $299,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $7.48B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.